MicroPort Neuro (2172) reported that on November 20, 2025, it resolved to grant a total of 500,000 share options under its share scheme adopted on July 12, 2023. The options have been granted to an employee responsible for key BCI hardware and software development, with a ten-year validity period and an exercise price set at HK$11.302 per share. No performance targets apply to these options, which are scheduled to vest evenly over five years.

The share scheme aims to enhance the employee’s motivation and personal stake in MicroPort Neuro (2172). Following this option grant, the remaining available shares for future grants total 50,255,510 shares, of which 5,826,581 may be allocated under the service provider limit.